The pLenti-TRE-CasRx-U6-gRNA vector was prepared by PCR, restriction digestion, and ligation. The U6 promoter and PAC were amplified from pLenti-CRISPR-V2 (addgene 52961). An SV40 early promoter was amplified from plenti4 (invitrogen). TRE was cut from pLenti6-CMV-Tight-DEST (Addgene_26433). rtTA3 was amplified and assembled from pLenti-CMV-rtTA3 Blast (Addgene 26429) and Fuw-M2-rtTA (Addgene 20342).
gRNA sequences were picked from the online source https://cas13design.nygenome.org/ (Wessels et al., 2020 (link)). Forward primers with 5′-AAAC overhang and reverse primer with 3′-AAAA overhang were annealed together and treated with polynucleotide kinase. Afterward, annealed oligo was ligated to pLenti-TRE-CasRx-U6 cut with BsmBI and treated with alkaline phosphatase. Sequences of all insertions were then verified by Sanger sequencing. Guide RNA sequences used are listed in Supplementary Table S1.
Free full text: Click here